This page includes a compilation of information and resources related to lingering or emerging new illnesses suffered by people following Covid and Covid vaccine related to the “spike protein.” Some are getting sick from this even if they had asymptomatic Covid or didn’t feel sick from the vaccination at the time. Symptoms can range from retina detachment, tinnitis, hearing problems, gastric problems, atrial fibrillation, hearing issues, and memory problems or brain fog, to heart attack, heart arrhythmia, stroke, fainting, blood clots, paralysis, muscle disorders, iliac vein collapse, weakness, heavy legs, and more.
Links to two videos are below. Many more resources follow, including links to doctors who can treat Covid and Covid vaccine injuries, and protocols you can consider following yourself at home.
(Medical definitions that follow are from Dr. Jordan Vaughn. Other info is from Front Line Covid-19 Care Alliance)
Long Covid/Long Vax:
Millions of individuals suffer from extensive, debilitating symptoms following exposure to the spike protein, either through viral exposure or vaccination. Microclots can cause a number of symptoms including postexertional malaise, fatigue, brain fog, shortness of breath, heart rhythm abnormalities, and chronic pain. Effective treatments address these symptoms by eliminating these microclots and restoring patients to health.
Understand the changes in small vessels with microclots
When microclots form in the body, they’re typically broken down easily and removed from the bloodstream. However, when the spike protein is introduced to the blood either through viral infection or vaccination, it causes the formation of amyloid fibrin microclots. These microclots are resistant to fibrinolysis, the body’s normal breakdown process. In some patients, they accumulate, damaging the endothelium in small blood vessels and inhibiting oxygen delivery to the body’s tissues.
These microclots cannot be viewed with a traditional microscope, nor can they always be detected with D-dimer measurements.
We are currently working to validate Flow Cytometry as a quantitative test for the amount of amyloid fibrin. Research directed towards understanding these microclots and the damage they cause to the endothelium will inform treatment protocols.